Family Medicine · Centerville, OH
NPI
1760487599
Since 2005
Specialty
Family Medicine
Code 207Q00000X
Group practices
2
Medicare group memberships
Hospitals
4
Hospital affiliations
1989 Miamisburg Centerville Rd, Suite 301
Centerville, OH, 45459
Phone (937) 434-7353
Groups this clinician bills Medicare through
Medicare paid, 2024
$77K
4,972 services
Medicare patients, 2024
259
Average age 75
Drug cost, 2024
$567K
10,197 prescriptions
Company payments, 2025
$345
From 7 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jeffrey B Gleick was code J1010 (injection, methylprednisolone acetate, 1 mg), 3,600 times for 33 patients. In total Jeffrey B Gleick billed 4,972 services in 38 codes, and Medicare paid $77K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2016-03-23.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1010 Injection, methylprednisolone acetate, 1 mg | Office | 3,600 | 33 | $0.10 | $356 |
| 99213 Office E&M - Established | Office | 260 | 143 | $51.80 | $13K |
| 99214 Office E&M - Established | Office | 230 | 173 | $73.43 | $17K |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 161 | 161 | $121.97 | $20K |
| G0444 Annual depression screening, 5 to 15 minutes | Office | 159 | 159 | $17.45 | $2,775 |
| 96372 Injection Administration | Office | 115 | 60 | $8.77 | $1,009 |
| G0008 Administration of influenza virus vaccine | Office | 71 | 70 | $30.41 | $2,159 |
| 90653 Vaccine Product | Office | 63 | 63 | $81.82 | $5,155 |
| J1040 Injection, methylprednisolone acetate, 80 mg | Office | 29 | 26 | $3.23 | $93.6 |
| 81003 Clinical Chemistry | Office | 26 | 16 | $2.20 | $57.2 |
| G0009 Administration of pneumococcal vaccine | Office | 20 | 20 | $30.40 | $608 |
| 90677 Vaccine Product | Office | 20 | 20 | $291.62 | $5,832 |
| 99496 Chronic, Principal, and Transitional Care Management | Office | 13 | 13 | $208.75 | $2,714 |
| 99495 Chronic, Principal, and Transitional Care Management | Office | 11 | 11 | $143.27 | $1,576 |
By year: 2022 $77K for 6,440 services; 2023 $84K for 5,735 services; 2024 $77K for 4,972 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 81003 Clinical Chemistry | 26 | 16 | $2.20 | $57.2 |
Medicare prescription drug claims, 2024
In 2024, the drug Jeffrey B Gleick prescribed most often to Medicare patients was Atorvastatin Calcium, with 597 prescriptions and refills. In total Jeffrey B Gleick wrote 10,197 Medicare prescriptions that cost $567K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 597 | 1,700 | 167 | $3,912 |
| Levothyroxine Sodium Generic | 476 | 1,284 | 123 | $4,679 |
| Amlodipine Besylate Generic | 339 | 946 | 91 | $1,046 |
| Omeprazole Generic | 306 | 804 | 87 | $2,842 |
| Lisinopril Generic | 277 | 753 | 79 | $986 |
| Rosuvastatin Calcium Generic | 267 | 726 | 76 | $2,009 |
| Losartan Potassium Generic | 259 | 691 | 66 | $1,795 |
| Pantoprazole Sodium Generic | 216 | 566 | 70 | $2,607 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 209 | 233 | 49 | $3,236 |
| Metformin Hcl Er Metformin Hcl | 200 | 496 | 56 | $1,041 |
| Pravastatin Sodium Generic | 199 | 522 | 48 | $2,142 |
| Metoprolol Succinate Generic | 199 | 559 | 58 | $2,101 |
| Tamsulosin Hcl Generic | 193 | 533 | 59 | $2,173 |
| Escitalopram Oxalate Generic | 184 | 430 | 51 | $1,227 |
| Allopurinol Generic | 165 | 403 | 38 | $1,201 |
Brand drugs: 1,016 claims; generic drugs: 9,163 claims; opioid claims: 120.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jeffrey B Gleick $345 ($345 in general payments such as food, travel and fees) from 7 companies. The largest payer was Abbvie Inc. with $171.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.